Location · Torrance, CA
Clinical trials in Torrance, CA
66 recruiting studies have a site in Torrance, and 3 of them accept healthy volunteers.
66 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
AstraZeneca
- Location
- Torrance, CA + 53 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 2
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Pulmovant, Inc.
- Location
- Torrance, CA + 12 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
Inhibikase Therapeutics
- Location
- Torrance, CA + 14 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Immunovant Sciences GmbH
- Location
- Torrance, CA + 54 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
AstraZeneca
- Location
- Torrance, CA + 206 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections
Macro Biologics, Inc.
- Location
- Torrance, CA + 4 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 2
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
LB Pharmaceuticals Inc.
- Location
- Torrance, CA + 25 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2/Phase 3
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Kardigan, Inc.
- Location
- Torrance, CA + 46 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
Corza Medical GmbH
- Location
- Torrance, CA + 8 other US sites
- Eligibility basics
- Ages 1 mo+
- RecruitingPhase 2
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in…
Apellis Pharmaceuticals, Inc.
- Location
- Torrance, CA + 77 other US sites
- Eligibility basics
- Ages 60+
- RecruitingPhase 2
Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia
Neurocrine Biosciences
- Location
- Torrance, CA + 17 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
DalCor Pharmaceuticals
- Location
- Torrance, CA + 112 other US sites
- Eligibility basics
- Ages 45+
- RecruitingPhase 2
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
BioMarin Pharmaceutical
- Location
- Torrance, CA + 30 other US sites
- Eligibility basics
- Ages 3–11
- Recruiting
SELUTION4BTK Trial
M.A. Med Alliance S.A.
- Location
- Torrance, CA + 24 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Neurocrine Biosciences
- Location
- Torrance, CA + 20 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
Abcentra
- Location
- Torrance, CA + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Kartos Therapeutics, Inc.
- Location
- Torrance, CA + 57 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
Glaukos Corporation
- Location
- Torrance, CA + 19 other US sites
- Eligibility basics
- Ages 2+